【摘要】：正近日,美國內(nèi)分泌醫(yī)師協(xié)會(AACE)和美國內(nèi)分泌學會(ACE)聯(lián)合頒布血脂管理指南,重拾了低密度脂蛋白膽固醇(LDL-C)目標值,對動脈粥樣硬化性心血管疾病(ASCVD)不同風險的患者設(shè)立不同的降脂目標值。極端風險:包括(1)LDL-C70 mg/dl后仍有進展性ASCVD(包括不穩(wěn)定型心絞痛)的患者;(2)確診心血管病的糖尿病、3/4期慢性腎
[Abstract]:Recently, the American Association of Endocrinologists (AACE) and the American Endocrine Society (ACE) jointly issued guidelines for the management of blood lipids, regaining the target value of low density lipoprotein cholesterol (LDL-C). Different lipid lowering targets were established for patients with different risk of (ASCVD) for atherosclerotic cardiovascular disease. Extreme risk: (1) patients with progressive ASCVD (including unstable angina pectoris) after LDL-C70 mg/dl; (2) diabetes with confirmed cardiovascular disease, stage 3 / 4 chronic kidney disease
【分類號】：R54
，

本文編號：2379656